世界のラコサミド市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Lacosamide Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5827 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、ラコサミドの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口錠剤、経口液剤、静脈注射）、用途別市場規模（成人、小児患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・ラコサミドの市場動向 ・企業の競争状況、市場シェア ・ラコサミドの種類別市場規模と予測2016-2027（経口錠剤、経口液剤、静脈注射） ・ラコサミドの用途別市場規模と予測2016-2027（成人、小児患者） ・ラコサミドの北米市場規模2016-2027（アメリカ、カナダ） ・ラコサミドの欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・ラコサミドのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ラコサミドの中南米市場規模2016-2027（メキシコ、ブラジル） ・ラコサミドの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（UCB、Teva、Amneal Pharmaceuticals、MSN Laboratories、Alembic Pharma、Glenmark、Aurobindo Pharma、Accord Healthcare、Mylan、Sun Pharma、Apotex） ・結論

Lacosamide (INN, formerly known as erlosamide, harkeroside, SPM 927, or ADD 234037), is a medication for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain. It is marketed under the trade name Vimpat.

Market Analysis and Insights: Global Lacosamide Market
The global Lacosamide market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Lacosamide market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Lacosamide market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Lacosamide market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Lacosamide market.

Global Lacosamide Scope and Market Size
Lacosamide market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Lacosamide market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral tablets
Oral solution
Intravenous

Segment by Application
Adults
Pediatric patients

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
UCB
Teva
Amneal Pharmaceuticals
MSN Laboratories
Alembic Pharma
Glenmark
Aurobindo Pharma
Accord Healthcare
Mylan
Sun Pharma
Apotex

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lacosamide Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral tablets
1.2.3 Oral solution
1.2.4 Intravenous
1.3 Market by Application
1.3.1 Global Lacosamide Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Lacosamide Market Perspective (2016-2027)
2.2 Lacosamide Growth Trends by Regions
2.2.1 Lacosamide Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Lacosamide Historic Market Share by Regions (2016-2021)
2.2.3 Lacosamide Forecasted Market Size by Regions (2022-2027)
2.3 Lacosamide Industry Dynamic
2.3.1 Lacosamide Market Trends
2.3.2 Lacosamide Market Drivers
2.3.3 Lacosamide Market Challenges
2.3.4 Lacosamide Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Lacosamide Players by Revenue
3.1.1 Global Top Lacosamide Players by Revenue (2016-2021)
3.1.2 Global Lacosamide Revenue Market Share by Players (2016-2021)
3.2 Global Lacosamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Lacosamide Revenue
3.4 Global Lacosamide Market Concentration Ratio
3.4.1 Global Lacosamide Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lacosamide Revenue in 2020
3.5 Lacosamide Key Players Head office and Area Served
3.6 Key Players Lacosamide Product Solution and Service
3.7 Date of Enter into Lacosamide Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Lacosamide Breakdown Data by Type
4.1 Global Lacosamide Historic Market Size by Type (2016-2021)
4.2 Global Lacosamide Forecasted Market Size by Type (2022-2027)

5 Lacosamide Breakdown Data by Application
5.1 Global Lacosamide Historic Market Size by Application (2016-2021)
5.2 Global Lacosamide Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Lacosamide Market Size (2016-2027)
6.2 North America Lacosamide Market Size by Type
6.2.1 North America Lacosamide Market Size by Type (2016-2021)
6.2.2 North America Lacosamide Market Size by Type (2022-2027)
6.2.3 North America Lacosamide Market Size by Type (2016-2027)
6.3 North America Lacosamide Market Size by Application
6.3.1 North America Lacosamide Market Size by Application (2016-2021)
6.3.2 North America Lacosamide Market Size by Application (2022-2027)
6.3.3 North America Lacosamide Market Size by Application (2016-2027)
6.4 North America Lacosamide Market Size by Country
6.4.1 North America Lacosamide Market Size by Country (2016-2021)
6.4.2 North America Lacosamide Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Lacosamide Market Size (2016-2027)
7.2 Europe Lacosamide Market Size by Type
7.2.1 Europe Lacosamide Market Size by Type (2016-2021)
7.2.2 Europe Lacosamide Market Size by Type (2022-2027)
7.2.3 Europe Lacosamide Market Size by Type (2016-2027)
7.3 Europe Lacosamide Market Size by Application
7.3.1 Europe Lacosamide Market Size by Application (2016-2021)
7.3.2 Europe Lacosamide Market Size by Application (2022-2027)
7.3.3 Europe Lacosamide Market Size by Application (2016-2027)
7.4 Europe Lacosamide Market Size by Country
7.4.1 Europe Lacosamide Market Size by Country (2016-2021)
7.4.2 Europe Lacosamide Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Lacosamide Market Size (2016-2027)
8.2 Asia-Pacific Lacosamide Market Size by Type
8.2.1 Asia-Pacific Lacosamide Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Lacosamide Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Lacosamide Market Size by Type (2016-2027)
8.3 Asia-Pacific Lacosamide Market Size by Application
8.3.1 Asia-Pacific Lacosamide Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Lacosamide Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Lacosamide Market Size by Application (2016-2027)
8.4 Asia-Pacific Lacosamide Market Size by Region
8.4.1 Asia-Pacific Lacosamide Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Lacosamide Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Lacosamide Market Size (2016-2027)
9.2 Latin America Lacosamide Market Size by Type
9.2.1 Latin America Lacosamide Market Size by Type (2016-2021)
9.2.2 Latin America Lacosamide Market Size by Type (2022-2027)
9.2.3 Latin America Lacosamide Market Size by Type (2016-2027)
9.3 Latin America Lacosamide Market Size by Application
9.3.1 Latin America Lacosamide Market Size by Application (2016-2021)
9.3.2 Latin America Lacosamide Market Size by Application (2022-2027)
9.3.3 Latin America Lacosamide Market Size by Application (2016-2027)
9.4 Latin America Lacosamide Market Size by Country
9.4.1 Latin America Lacosamide Market Size by Country (2016-2021)
9.4.2 Latin America Lacosamide Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Lacosamide Market Size (2016-2027)
10.2 Middle East & Africa Lacosamide Market Size by Type
10.2.1 Middle East & Africa Lacosamide Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Lacosamide Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Lacosamide Market Size by Type (2016-2027)
10.3 Middle East & Africa Lacosamide Market Size by Application
10.3.1 Middle East & Africa Lacosamide Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Lacosamide Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Lacosamide Market Size by Application (2016-2027)
10.4 Middle East & Africa Lacosamide Market Size by Country
10.4.1 Middle East & Africa Lacosamide Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Lacosamide Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 UCB
11.1.1 UCB Company Details
11.1.2 UCB Business Overview
11.1.3 UCB Lacosamide Introduction
11.1.4 UCB Revenue in Lacosamide Business (2016-2021)
11.1.5 UCB Recent Development
11.2 Teva
11.2.1 Teva Company Details
11.2.2 Teva Business Overview
11.2.3 Teva Lacosamide Introduction
11.2.4 Teva Revenue in Lacosamide Business (2016-2021)
11.2.5 Teva Recent Development
11.3 Amneal Pharmaceuticals
11.3.1 Amneal Pharmaceuticals Company Details
11.3.2 Amneal Pharmaceuticals Business Overview
11.3.3 Amneal Pharmaceuticals Lacosamide Introduction
11.3.4 Amneal Pharmaceuticals Revenue in Lacosamide Business (2016-2021)
11.3.5 Amneal Pharmaceuticals Recent Development
11.4 MSN Laboratories
11.4.1 MSN Laboratories Company Details
11.4.2 MSN Laboratories Business Overview
11.4.3 MSN Laboratories Lacosamide Introduction
11.4.4 MSN Laboratories Revenue in Lacosamide Business (2016-2021)
11.4.5 MSN Laboratories Recent Development
11.5 Alembic Pharma
11.5.1 Alembic Pharma Company Details
11.5.2 Alembic Pharma Business Overview
11.5.3 Alembic Pharma Lacosamide Introduction
11.5.4 Alembic Pharma Revenue in Lacosamide Business (2016-2021)
11.5.5 Alembic Pharma Recent Development
11.6 Glenmark
11.6.1 Glenmark Company Details
11.6.2 Glenmark Business Overview
11.6.3 Glenmark Lacosamide Introduction
11.6.4 Glenmark Revenue in Lacosamide Business (2016-2021)
11.6.5 Glenmark Recent Development
11.7 Aurobindo Pharma
11.7.1 Aurobindo Pharma Company Details
11.7.2 Aurobindo Pharma Business Overview
11.7.3 Aurobindo Pharma Lacosamide Introduction
11.7.4 Aurobindo Pharma Revenue in Lacosamide Business (2016-2021)
11.7.5 Aurobindo Pharma Recent Development
11.8 Accord Healthcare
11.8.1 Accord Healthcare Company Details
11.8.2 Accord Healthcare Business Overview
11.8.3 Accord Healthcare Lacosamide Introduction
11.8.4 Accord Healthcare Revenue in Lacosamide Business (2016-2021)
11.8.5 Accord Healthcare Recent Development
11.9 Mylan
11.9.1 Mylan Company Details
11.9.2 Mylan Business Overview
11.9.3 Mylan Lacosamide Introduction
11.9.4 Mylan Revenue in Lacosamide Business (2016-2021)
11.9.5 Mylan Recent Development
11.10 Sun Pharma
11.10.1 Sun Pharma Company Details
11.10.2 Sun Pharma Business Overview
11.10.3 Sun Pharma Lacosamide Introduction
11.10.4 Sun Pharma Revenue in Lacosamide Business (2016-2021)
11.10.5 Sun Pharma Recent Development
11.11 Apotex
11.11.1 Apotex Company Details
11.11.2 Apotex Business Overview
11.11.3 Apotex Lacosamide Introduction
11.11.4 Apotex Revenue in Lacosamide Business (2016-2021)
11.11.5 Apotex Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Lacosamide Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral tablets
Table 3. Key Players of Oral solution
Table 4. Key Players of Intravenous
Table 5. Global Lacosamide Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Lacosamide Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Lacosamide Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Lacosamide Market Share by Regions (2016-2021)
Table 9. Global Lacosamide Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Lacosamide Market Share by Regions (2022-2027)
Table 11. Lacosamide Market Trends
Table 12. Lacosamide Market Drivers
Table 13. Lacosamide Market Challenges
Table 14. Lacosamide Market Restraints
Table 15. Global Lacosamide Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Lacosamide Market Share by Players (2016-2021)
Table 17. Global Top Lacosamide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lacosamide as of 2020)
Table 18. Ranking of Global Top Lacosamide Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Lacosamide Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Lacosamide Product Solution and Service
Table 22. Date of Enter into Lacosamide Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Lacosamide Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Lacosamide Revenue Market Share by Type (2016-2021)
Table 26. Global Lacosamide Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Lacosamide Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Lacosamide Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Lacosamide Revenue Market Share by Application (2016-2021)
Table 30. Global Lacosamide Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Lacosamide Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Lacosamide Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Lacosamide Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Lacosamide Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Lacosamide Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Lacosamide Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Lacosamide Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Lacosamide Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Lacosamide Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Lacosamide Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Lacosamide Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Lacosamide Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Lacosamide Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Lacosamide Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Lacosamide Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Lacosamide Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Lacosamide Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Lacosamide Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Lacosamide Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Lacosamide Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Lacosamide Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Lacosamide Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Lacosamide Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Lacosamide Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Lacosamide Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Lacosamide Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Lacosamide Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Lacosamide Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Lacosamide Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Lacosamide Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Lacosamide Market Size by Country (2022-2027) & (US$ Million)
Table 62. UCB Company Details
Table 63. UCB Business Overview
Table 64. UCB Lacosamide Product
Table 65. UCB Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 66. UCB Recent Development
Table 67. Teva Company Details
Table 68. Teva Business Overview
Table 69. Teva Lacosamide Product
Table 70. Teva Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 71. Teva Recent Development
Table 72. Amneal Pharmaceuticals Company Details
Table 73. Amneal Pharmaceuticals Business Overview
Table 74. Amneal Pharmaceuticals Lacosamide Product
Table 75. Amneal Pharmaceuticals Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 76. Amneal Pharmaceuticals Recent Development
Table 77. MSN Laboratories Company Details
Table 78. MSN Laboratories Business Overview
Table 79. MSN Laboratories Lacosamide Product
Table 80. MSN Laboratories Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 81. MSN Laboratories Recent Development
Table 82. Alembic Pharma Company Details
Table 83. Alembic Pharma Business Overview
Table 84. Alembic Pharma Lacosamide Product
Table 85. Alembic Pharma Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 86. Alembic Pharma Recent Development
Table 87. Glenmark Company Details
Table 88. Glenmark Business Overview
Table 89. Glenmark Lacosamide Product
Table 90. Glenmark Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 91. Glenmark Recent Development
Table 92. Aurobindo Pharma Company Details
Table 93. Aurobindo Pharma Business Overview
Table 94. Aurobindo Pharma Lacosamide Product
Table 95. Aurobindo Pharma Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 96. Aurobindo Pharma Recent Development
Table 97. Accord Healthcare Company Details
Table 98. Accord Healthcare Business Overview
Table 99. Accord Healthcare Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 100. Accord Healthcare Recent Development
Table 101. Mylan Company Details
Table 102. Mylan Business Overview
Table 103. Mylan Lacosamide Product
Table 104. Mylan Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 105. Mylan Recent Development
Table 106. Sun Pharma Company Details
Table 107. Sun Pharma Business Overview
Table 108. Sun Pharma Lacosamide Product
Table 109. Sun Pharma Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 110. Sun Pharma Recent Development
Table 111. Apotex Company Details
Table 112. Apotex Business Overview
Table 113. Apotex Lacosamide Product
Table 114. Apotex Revenue in Lacosamide Business (2016-2021) & (US$ Million)
Table 115. Apotex Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lacosamide Market Share by Type: 2020 VS 2027
Figure 2. Oral tablets Features
Figure 3. Oral solution Features
Figure 4. Intravenous Features
Figure 5. Global Lacosamide Market Share by Application: 2020 VS 2027
Figure 6. Adults Case Studies
Figure 7. Pediatric patients Case Studies
Figure 8. Lacosamide Report Years Considered
Figure 9. Global Lacosamide Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Lacosamide Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Lacosamide Market Share by Regions: 2020 VS 2027
Figure 12. Global Lacosamide Market Share by Regions (2022-2027)
Figure 13. Global Lacosamide Market Share by Players in 2020
Figure 14. Global Top Lacosamide Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lacosamide as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Lacosamide Revenue in 2020
Figure 16. Global Lacosamide Revenue Market Share by Type (2016-2021)
Figure 17. Global Lacosamide Revenue Market Share by Type (2022-2027)
Figure 18. North America Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Lacosamide Market Share by Type (2016-2027)
Figure 20. North America Lacosamide Market Share by Application (2016-2027)
Figure 21. North America Lacosamide Market Share by Country (2016-2027)
Figure 22. United States Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Lacosamide Market Share by Type (2016-2027)
Figure 26. Europe Lacosamide Market Share by Application (2016-2027)
Figure 27. Europe Lacosamide Market Share by Country (2016-2027)
Figure 28. Germany Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Lacosamide Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Lacosamide Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Lacosamide Market Share by Region (2016-2027)
Figure 38. China Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Lacosamide Market Share by Type (2016-2027)
Figure 46. Latin America Lacosamide Market Share by Application (2016-2027)
Figure 47. Latin America Lacosamide Market Share by Country (2016-2027)
Figure 48. Mexico Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Lacosamide Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Lacosamide Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Lacosamide Market Share by Country (2016-2027)
Figure 54. Turkey Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Lacosamide Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UCB Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 58. Teva Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 59. Amneal Pharmaceuticals Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 60. MSN Laboratories Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 61. Alembic Pharma Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 62. Glenmark Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 63. Aurobindo Pharma Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 64. Accord Healthcare Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 65. Mylan Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 66. Sun Pharma Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 67. Apotex Revenue Growth Rate in Lacosamide Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

---